Post Mucormycosis Rehabilitation By Prosthodontists In Tamil Nadu & Pondicherry: KAP-Questionnaire Based Study
Abstract
Background: Covid-19 pandemic during 2019 left high mortality rates with mucormycosis (black fungus) as its deadly complication. The spread of black fungus has become global; hence it’s crucial to undertake necessary measures to prevent its spread. Prosthodontists have an inevitable role in the management of mucormycosis and educating the patients regarding the same. The diagnosis of mucormycosis is quite challenging. The treatment should start as quick as possible in order to decrease the death rates. Hence, the knowledge of clinical features and risk factors of mucormycosis is necessary for the prosthodontist in order to provide prompt treatment to the patient.
Materials and methods: A cross-sectional questionnaire based online survey was undertaken amongst 183 Prosthodontists in Tamilnadu and Pondicherry. The questionnaire consisted of 15 questions which evaluated their knowledge, awareness and practice related aspects towards management of postsurgical mucormycosis patients. Statistical analysis was done by using t-test, ANOVA, Pearson and correlation tests. The statistical significance was defined at P < 0.05.
Results: 93% of the study participants were private practitioners in the age group of 25 – 45 years. 106 out of 183 participants had good knowledge about clinical features, prevalent conditions (n=106) and its mode of spread(n=106). They have reported using various prosthesis, grafts and obturators for management of post surgical mucormycosis defects.
Conclusion: Most of the participants were aware about mucormycosis, had reported cases of mucormycosis during Covid-19 and had also employed different methods for prosthetic rehabilitation of patients. However, due to the increase of mucormycosis cases during Covid-19, the practitioners have adopted various methods for rehabilitation. Hollow bulb obturators were found to be the popular mode of rehabilitation. Further research is necessary to develop a standardized protocol for management of post mucormycosis defects.
References
Pilmis B, Alanio A, Lortholary O, Lanternier F. Recent advances in the understanding and management of mucormycosis. F1000Res. 2018;7:1429
Brown SR, Shah IA, Grinstead M. Rhinocerebralmucormycosis caused by Apophysomyces elegans. American Journal of Rhinology. 1998;12(4):289–92.
Ramadorai A, Ravi P, Narayanan V. Rhinocerebralmucormycosis: A prospective analysis of an effective treatment protocol. Annals of Maxillofacial Surgery. 2019;9(1):192–6.
Harrill WC, Stewart MG, Lee AG, Cernoch P. Chronic rhinocerebralmucormycosis. The Laryngoscope. 1996;106:1292–7
Kontoyiannis DP, Lewis RE. How I treat mucormycosis. Blood.2011;118(5):1216–24.
Brettholz AM, Mccauley SO. Mucormycosis: Early Identification of a Deadly Fungus. J Pediatr Oncol Nurs.2018;35(4):257–66
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–74
Naming the coronavirus disease (COVID 19) and the virus that causes it, c2020. 2020.
Rio D, Malani C. novel coronavirus important information for clinicians. JAMA. 2020;323:1039–40
Onder G, Rezza G, Brusaferro S. Case fatality rate and characteristics of patients dying in relation to COVID 19 in Italy. JAMA. 2020;323:1775–6.
Bhansali A, Bhadada S, Sharma A, Suresh V, Gupta A, Singh P. Presentation and outcome of rhino orbital cerebral mucormycosis in patients with diabetes. Postgrad Med J. 2004;80:670–4..
Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a viral land: A tale of two pathogens. Indian J Ophthalmol . 2021;69(2):244–52
Balushi AA, Ajmi AA, Sinani QA, Menon V, Berieki ZA, Shezawi AA, et al. COVID-19-associated mucormycosis: An opportunistic fungal infection. A case series and review. Int J Infect Dis. 2022;121:203–10
Sen M, Honavar SG, Bansal R, Sengupta S, Rao R, Kim U. Epidemiology, clinical profile, management, and outcome of COVID 19 associated rhino orbital cerebral mucormycosis in 2826 patients in India Collaborative OPAI IJO Study on. COSMIC), Report 1 Indian J. 2021;19:1670–92.
Swapnil C, Gaurav L. Rehabilitation of post Covid mucormycosis maxillectomy defect with hollow obturator: A case series. IP Ann ProsthodontRestor Dent. 2022;2022.
Rathee M. Reconstruction and Rehabilitation of Maxillary Defects Secondary to Mucormycosis”. Saudi J Oral Dent Res. 2022;7(1):1–7.
Ndrades P, Militsakh O, Hanasono MM, Rieger J, Rosenthal EL. Current strategies in reconstruction of maxillectomy defects. Arch Otolaryngol Head Neck Surg. 2011;137(8):806–12.
Rani S, Gupta S, Verma M. Hollow bulb one piece maxillary definitive obturator-A simplified approach. Contemporary clinical dentistry. 2017;8(1).
Wu Y-L, Schaaf NG. Comparison of weight reduction in different designs of solid and hollow obturator prostheses. J Prosthet Dent. 1989;62(2):214–7
Jayagayathri R, Mohanty P, Yadalla D, Bakthavatchalam J, Rangarajan V, Maneksha V. Knowledge, attitude, and practice toward mucormycosis among patients presenting to six tertiary eye care hospitals in South India - A multicentric online questionnaire based survey. Indian J. 2022;70:2158–62.
Copyright (c) 2024 The Journal of Clinical Prosthodontics and Implantology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The entire contents of the Journal of Clinical Prosthodontics and Implantology are protected under Indian and international copyrights. The Journal, however, grants to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute derivative works in any digital medium for any reasonable non-commercial purpose, subject to proper attribution of authorship and ownership of the rights.
